{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:35:19Z","timestamp":1793932519185,"version":"4.8.0"},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T00:00:00Z","timestamp":1350950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Pathology"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple system atrophy is a neurodegenerative disorder characterized pathologically by abnormal accumulations of \u03b1\u2010synuclein in the cytoplasm of oligodendrocytes, which are termed glial cytoplasmic inclusions (<jats:styled-content style=\"fixed-case\">GCIs<\/jats:styled-content>). Oligodendrocytes are responsible for myelinating axons and providing neurotrophic support, but in <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content>, myelin loss, axonal loss and gliosis are consistent features suggesting that <jats:styled-content style=\"fixed-case\">GCIs<\/jats:styled-content> play a central role in disease pathogenesis. Oligodendroglial, myelin and axonal degeneration are also features of multiple sclerosis (<jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>) in which recent studies have highlighted the robust remyelination capacity of the central nervous system (<jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>). The cells responsible for remyelination are called oligodendroglial precursor cells (<jats:styled-content style=\"fixed-case\">OPCs<\/jats:styled-content>). In this study, we investigated the role of <jats:styled-content style=\"fixed-case\">OPCs<\/jats:styled-content> in the pathogenesis of <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content> and progressive supranuclear palsy (<jats:styled-content style=\"fixed-case\">PSP<\/jats:styled-content>), a neurodegenerative disease in which neuropathological changes include oligodendroglial inclusions composed of microtubule\u2010associated protein tau. Despite the lability of <jats:styled-content style=\"fixed-case\">OPC<\/jats:styled-content>\u2010specific antigens, we successfully identified <jats:styled-content style=\"fixed-case\">OPCs<\/jats:styled-content> and demonstrated that tau and \u03b1\u2010synuclein do not accumulate in <jats:styled-content style=\"fixed-case\">OPCs<\/jats:styled-content>. We also showed that the density of <jats:styled-content style=\"fixed-case\">OPCs<\/jats:styled-content> was increased in a white matter region of the <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content> brain, which is also severely affected by <jats:styled-content style=\"fixed-case\">GCIs<\/jats:styled-content> and myelin degeneration. These findings raise the possibility that <jats:styled-content style=\"fixed-case\">OPCs<\/jats:styled-content> could be available to repair disease\u2010associated damage in <jats:styled-content style=\"fixed-case\">MSA<\/jats:styled-content>, consistent with their biological function.<\/jats:p>","DOI":"10.1111\/j.1750-3639.2012.00637.x","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T12:14:04Z","timestamp":1348056844000},"page":"263-273","source":"Crossref","is-referenced-by-count":82,"title":["Identification and Quantification of Oligodendrocyte Precursor Cells in Multiple System Atrophy, Progressive Supranuclear Palsy and <scp>P<\/scp>arkinson's Disease"],"prefix":"10.1111","volume":"23","author":[{"given":"Zeshan","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Molecular Neuroscience UCL Institute of Neurology  London UK"},{"name":"Queen Square Brain Bank UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine T.","family":"Asi","sequence":"additional","affiliation":[{"name":"Department of Molecular Neuroscience UCL Institute of Neurology  London UK"},{"name":"Queen Square Brain Bank UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lees","sequence":"additional","affiliation":[{"name":"Department of Molecular Neuroscience UCL Institute of Neurology  London UK"},{"name":"Queen Square Brain Bank UCL Institute of Neurology  London UK"},{"name":"Reta Lila Weston Institute of Neurological Studies UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[{"name":"Department of Molecular Neuroscience UCL Institute of Neurology  London UK"},{"name":"Queen Square Brain Bank UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[{"name":"Department of Molecular Neuroscience UCL Institute of Neurology  London UK"},{"name":"Queen Square Brain Bank UCL Institute of Neurology  London UK"},{"name":"Reta Lila Weston Institute of Neurological Studies UCL Institute of Neurology  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,23]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2010.01093.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/249577a0"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-17-06404.2000"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO;2-E"},{"key":"e_1_2_8_6_1","volume-title":"Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders","author":"Dickson D","year":"2003"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2480"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1789.2007.00855.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0672-3"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21018"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/embo-reports\/kvf109"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr014"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(84)90037-6"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65617-9"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0378-1"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2495"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh303"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2006.01.007"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(89)90219-0"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/117.2.235"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025747832215"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181b66f1b"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070201"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.07.007"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1740925X09990342"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70288-1"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00407-8"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21465"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.01.032"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63730-3"}],"container-title":["Brain Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1750-3639.2012.00637.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1750-3639.2012.00637.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:21:29Z","timestamp":1697394089000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1750-3639.2012.00637.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,23]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/j.1750-3639.2012.00637.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00637.x","archive":["Portico"],"relation":{},"ISSN":["1015-6305","1750-3639"],"issn-type":[{"value":"1015-6305","type":"print"},{"value":"1750-3639","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,23]]}}}